IART Q1 2025 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$383M+3.7% YoY

Gross Profit

$194M50.8% margin

Operating Income

-$15M-4.0% margin

Net Income

-$25M-6.6% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

-13.6%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$40M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$4.1B

Total Liabilities

$2.5B

Stockholders' Equity

$1.5B

Cash & Equivalents

$239M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$383M	$369M	+3.7%
Gross Profit	$194M	$207M	-6.0%
Operating Income	-$15M	$4M	-490.9%
Net Income	-$25M	-$3M	-670.9%

Revenue Segments

Codman Specialty Surgical

$281M73%

Tissue Technologies

$102M27%

Geographic Segments

UNITED STATES

$282M74%

Asia Pacific

$45M12%

Europe

$35M9%

Rest Of The World

$20M5%